- Home
- DLNG vs ARTV Comparison
DLNG vs ARTV Comparison
Compare DLNG & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLNG
- ARTV
- Stock Information
- Founded
- DLNG 2013
- ARTV 2019
- Country
- DLNG Greece
- ARTV United States
- Employees
- DLNG N/A
- ARTV N/A
- Industry
- DLNG Marine Transportation
- ARTV
- Sector
- DLNG Consumer Discretionary
- ARTV
- Exchange
- DLNG Nasdaq
- ARTV NYSE
- Market Cap
- DLNG 157.7M
- ARTV 186.1M
- IPO Year
- DLNG 2013
- ARTV 2024
- Fundamental
- Price
- DLNG $4.14
- ARTV $3.77
- Analyst Decision
- DLNG
- ARTV Strong Buy
- Analyst Count
- DLNG 0
- ARTV 6
- Target Price
- DLNG N/A
- ARTV $21.00
- AVG Volume (30 Days)
- DLNG 87.9K
- ARTV 81.5K
- Earning Date
- DLNG 03-26-2025
- ARTV 03-04-2025
- Dividend Yield
- DLNG 2.36%
- ARTV N/A
- EPS Growth
- DLNG 42.98
- ARTV N/A
- EPS
- DLNG 0.99
- ARTV N/A
- Revenue
- DLNG $151,689,000.00
- ARTV $2,601,000.00
- Revenue This Year
- DLNG N/A
- ARTV N/A
- Revenue Next Year
- DLNG N/A
- ARTV N/A
- P/E Ratio
- DLNG $4.27
- ARTV N/A
- Revenue Growth
- DLNG N/A
- ARTV N/A
- 52 Week Low
- DLNG $2.27
- ARTV $3.37
- 52 Week High
- DLNG $5.65
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- DLNG 28.85
- ARTV N/A
- Support Level
- DLNG $4.21
- ARTV N/A
- Resistance Level
- DLNG $4.40
- ARTV N/A
- Average True Range (ATR)
- DLNG 0.23
- ARTV 0.00
- MACD
- DLNG -0.04
- ARTV 0.00
- Stochastic Oscillator
- DLNG 4.44
- ARTV 0.00
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.